1. Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II). Issue 3 (June 2020) Authors: Atkinson, Victoria; Sandhu, Shahneen; Hospers, Geke; Long, Georgina V.; Aglietta, Massimo; Ferrucci, Pier F.; Tulyte, Skaiste; Cappellini, Gian Carlo Antonini; Soriano, Virtudes; Ali, Sayed; Poprach, Alexandr; Cesas, Alvydas; Rodriguez-Abreu, Delvys; Lau, Mike; de Jong, Egbert; Legenne, Philippe;... Journal: Melanoma research Issue: Volume 30:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗